Contenu disponible en anglais seulement.
Bulletin de la Bourse
CI Bio-Revolution ETF (CDNA) inscrit à la Bourse de Toronto
25 février 2022
Issuer: CI Bio-Revolution ETF ("CI ETF")
| Security | Symbol | Issued and Outstanding Securities | Reserved Securities | Issue Price |
|---|---|---|---|---|
| Common Units (the "Units") | CDNA | 50,000 | None | C$20.00 |
| Listing category: | Non-Corporate |
| Trading currency | CDN$ |
| Transaction: | Initial public offering (the "Offering") of Units. |
| Listing date: | February 28, 2022 (as at 5:01 p.m.) in anticipation of closing of the Offering. |
| Anticipated closing date: | March 1, 2022 (prior to the opening). |
| Posted for trading date: | March 1, 2022 (at the opening) subject to confirmation of closing of the Offering. |
| Other market(s): | None |
| Designated market maker: | BMO Nesbitt Burns Inc. |
| Security ownership registration: | CDS book entry only system and Non-Certificated Issue. |
| Investor relations: | Geraldo Ferreira Senior Vice-President, Investment and Product Management CI Global Asset Management 416-681-7723 gferreira@ci.com |
| Incorporation: | An exchange traded mutual fund established under the laws of the Province of Ontario pursuant to the amended and restated declaration of trust dated February 17, 2022. |
| Manager: | CI Investments Inc. |
| Fiscal year end: | December 31 |
| Nature of business: | CI ETF seeks to replicate, to the extent reasonably possible, the performance of a global biotechnology and genomics industry index, net of expenses. Currently, CI ETF seeks to replicate the performance of the Solactive Global Genomics Immunology and Medical Revolution CAD Hedged Index NTR (the "Index"). The Index intends to track the performance of companies that have business operations in the global biotechnology and genomics industry using the ARTIS® classification system. The Index hedges foreign currency exposure back to Canadian dollars. |
| Transfer agent and registrar: | TSX Trust Company at its principal office in Toronto. |
| Dividends: | Cash distributions of income, if any, on the Units will be paid quarterly. |
| Sponsorship: | Not applicable. |
| Offering document: | Prospectus dated February 17, 2022 (the "Prospectus") which is available at . Capitalized terms not otherwise defined herein are as defined in the Prospectus. |
| Initial public offering: | 50,000 Units will be issued at a subscription price of C$20.00 per Unit. CI ETF is authorized to issue an unlimited number of Units, each of which represents an undivided interest in the net assets of CI ETF. The Units of CI ETF are being issued and sold on a continuous basis and there is no maximum number of Units that may be issued. |
| TSX contact: | Selma Thaver, Director, TSX Listings |